HSBC Holdings
LEGN icon

HSBC Holdings’s Legend Biotech LEGN Stock Holding History

HSBC Holdings’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-40,994
Closed -$2.75M – 2828
2023
Q3 		$2.75M Buy
+40,994
New +$2.85M ﹤0.01% 1317

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

HSBC Holdings's LEGN Position: Q1 2026 in Review

HSBC Holdings reduced its Legend Biotech (LEGN) stake by 17% in Q1 2026, selling an estimated $851K and leaving 221,475 shares worth $4.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1246.

HSBC Holdings first reported a position in LEGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $19.3M in Q3 2024. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • HSBC Holdings held 221,475 shares of Legend Biotech worth $4.01M as of Q1 2026.
  • HSBC Holdings sold 44,659 Legend Biotech shares in Q1 2026, an estimated $851K.
  • Legend Biotech made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1246 holding.
  • HSBC Holdings first reported a position in Legend Biotech in Q4 2021 and has held it in 18 quarters since.
  • HSBC Holdings's Legend Biotech position peaked at $19.3M in Q3 2024.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.